Literature DB >> 18755325

High risk of vitamin D deficiency in children with sickle cell disease.

Alisha J Rovner1, Virginia A Stallings, Deborah A Kawchak, Joan I Schall, Kwaku Ohene-Frempong, Babette S Zemel.   

Abstract

Vitamin D is a particularly concerning nutrient for children with homozygous SS sickle cell disease (SCD-SS) due to their increased skin melanin concentrations, reduced levels of physical activity, and poor vitamin D intake. The goal of this study was to compare the vitamin D status of children with SCD-SS to healthy African-American children living in the same geographic area. Growth, dietary intake, serum 25-hydroxyvitamin D [25(OH)D], and intact parathyroid hormone (iPTH) concentrations were measured in 61 African-American subjects with SCD-SS and 89 healthy African-American control subjects age 5 to 18 years from the Philadelphia, PA, region (latitude 39.95 degrees N). Median serum 25(OH)D concentrations were 15 ng/mL (95% confidence interval [CI]: 13, 17) in subjects with SCD-SS and 21 ng/mL (95% CI: 18, 22) in healthy control subjects (P<0.0002). Vitamin D deficiency [25(OH)D<11 mg/mL] was found in 33% of subjects with SCD-SS and 9% of healthy control subjects (P<0.001); 25% of subjects with SCD-SS and 17% of healthy control subjects had elevated iPTH [(>59 rhog/mL), P<0.05]. Ninety-three percent of subjects with SCD-SS and 90% of healthy subjects had vitamin D insufficiency [25(OH)D<30 mg/mL]. The risk of vitamin D deficiency among subjects with SCD-SS was 5.3 (95% CI: 2.5, 8.2) times greater than control subjects, adjusted for season and age. Poor vitamin D status was prevalent in children with SCD-SS and healthy African-American children living in the same geographic area. However, children with SCD-SS were at greater risk for vitamin D deficiency than healthy African-American children.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18755325     DOI: 10.1016/j.jada.2008.06.433

Source DB:  PubMed          Journal:  J Am Diet Assoc        ISSN: 0002-8223


  21 in total

1.  Vitamin D deficiency and comorbidities in children with sickle cell anemia.

Authors:  Tara Christine Jackson; Melissa Jo Krauss; Michael Rutledge Debaun; Robert Charles Strunk; Ana Maria Arbeláez
Journal:  Pediatr Hematol Oncol       Date:  2012-04       Impact factor: 1.969

Review 2.  Vitamin D supplementation for sickle cell disease.

Authors:  Htoo Htoo Kyaw Soe; Adinegara Bl Abas; Nan Nitra Than; Han Ni; Jaspal Singh; Abdul Razzak Bin Mohd Said; Ifeyinwa Osunkwo
Journal:  Cochrane Database Syst Rev       Date:  2017-01-20

Review 3.  A review on vitamin d deficiency treatment in pediatric patients.

Authors:  Ji Yeon Lee; Tsz-Yin So; Jennifer Thackray
Journal:  J Pediatr Pharmacol Ther       Date:  2013-10

4.  Height-corrected low bone density associates with severe outcomes in sickle cell disease: SCCRIP cohort study results.

Authors:  Oyebimpe O Adesina; James G Gurney; Guolian Kang; Martha Villavicencio; Jason R Hodges; Wassim Chemaitilly; Sue C Kaste; Babette S Zemel; Jane S Hankins
Journal:  Blood Adv       Date:  2019-05-14

5.  Response to Long-term Vitamin D Therapy for Bone Disease in Children With Sickle Cell Disease.

Authors:  Kristen M Williams; Margaret T Lee; Maureen Licursi; Gary M Brittenham; Ilene Fennoy
Journal:  J Pediatr Hematol Oncol       Date:  2018-08       Impact factor: 1.289

6.  Vitamin D Deficiency and Its Association with Inflammatory Markers, Lipid Profile and Regulatory T-cells in Pediatric Sickle Cell Disease Patients.

Authors:  Yesim Oztas; Selma Unal; Gulcin Eskandari; Lulufer Tamer; Nuriman Ozgunes
Journal:  Indian J Hematol Blood Transfus       Date:  2017-10-13       Impact factor: 0.900

7.  Safety and Efficacy of High-dose Daily Vitamin D3 Supplementation in Children and Young Adults With Sickle Cell Disease.

Authors:  Kelly A Dougherty; Chiara Bertolaso; Joan I Schall; Kim Smith-Whitley; Virginia A Stallings
Journal:  J Pediatr Hematol Oncol       Date:  2015-07       Impact factor: 1.289

8.  Status of vitamin D in children with sickle cell disease living in Madrid, Spain.

Authors:  Carmen Garrido; Elena Cela; Cristina Beléndez; Cristina Mata; Jorge Huerta
Journal:  Eur J Pediatr       Date:  2012-09-05       Impact factor: 3.183

9.  No improvement in suboptimal vitamin A status with a randomized, double-blind, placebo-controlled trial of vitamin A supplementation in children with sickle cell disease.

Authors:  Kelly A Dougherty; Joan I Schall; Deborah A Kawchak; Michael H Green; Kwaku Ohene-Frempong; Babette S Zemel; Virginia A Stallings
Journal:  Am J Clin Nutr       Date:  2012-09-05       Impact factor: 7.045

10.  Comparative Effectiveness of a Six-Week Treatment Course of Vitamin D2 and D3 in Children With Sickle Cell Anemia in Steady State With Hypovitaminosis D: A Randomized Clinical Trial.

Authors:  Motunrayo Oluwabukola Adekunle; Adeyemi Oluwaseun Dada; Fidelis Olisamedua Njokanma; Adaobi Uzoamaka Solarin; Barakat Adeola Animasahun; Moriam Omolola Lamina
Journal:  J Hematol       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.